Conference App Sponsor: Pfizer Injectables
View analytic
Tuesday, July 31 • 2:30pm - 3:30pm
Biosimilars 101: What Everyone Should Know

Sign up or log in to save this to your schedule and see who's attending!

Download Presentation

  Abstract:   Biological pharmaceuticals are complex molecules used for the treatment of many different disease states. Due to their complexity, they have not been introduced in the United States. With the recent Health Reform Legislation, development and approval for similar biologics called biosimilars are possible. Biosimilars have been available in other countries for several years and these experiences could help shape what happens in the United States. This presentation will review the current patent cliff of small molecule medications, define biosimilar molecules, examine the arguments for and against biosimilar approval, and discuss expected criteria for approval.

Learning Objectives:
     1.    Describe the importance of biosimilars from a financial perspective.
     2.    Express the differences and similarities between branded biologics and biosimilars.
     3.    Describe the requirements necessary to gain approval and market biosimilars in the United States.


1 contact hour: MM, E, P                                                                     0262-0000-12-022-L03-P (K)


Craig Coulter

Craig Coulter serves as a contracting director in HealthTrust’s Pharmacy Strategic Sourcing department and is responsible for the GPO’s biosimilar strategy development and implementation. Prior to joining HealthTrust, Coulter served as the senior manager of a specialty fraud and... Read More →

Tuesday July 31, 2012 2:30pm - 3:30pm
Room 113

Attendees (0)